Back to Trades
Nicholson Nur
InsiderCIK 0001827317
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 3
- Companies
- 2
- Active
- 2026
Nicholson Nur has filed 7 SEC reports (2026), spread across 2 companies, totaling $16.4M in disclosed volume. Weighing $0 bought versus $269.8K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Sep 9 | KLRA Kailera Therapeutics, Inc. | Nicholson Nur | Insider | Award | $3.6M |
| Sep 9 | KLRA Kailera Therapeutics, Inc. | Nicholson Nur | Insider | Other | $0 |
| May 14 | APLS Apellis Pharmaceuticals, Inc. | Nicholson Nur | Insider | Grant | $12.6M |
| Jan 30 | APLS Apellis Pharmaceuticals, Inc. | Nicholson Nur | Chief Technical Officer | Grant | $0 |
| Jan 23 | APLS Apellis Pharmaceuticals, Inc. | Nicholson Nur | Chief Technical Officer | Sell | $168.1K |
| Jan 21 | APLS Apellis Pharmaceuticals, Inc. | Nicholson Nur | Chief Technical Officer | Sell | $43.6K |
| Jan 15 | APLS Apellis Pharmaceuticals, Inc. | Nicholson Nur | Chief Technical Officer | Sell | $58.1K |
7 filings